Keywords: astrazeneca, seroquel, shows, potential, bolder, ii, trial

AstraZeneca's Seroquel shows potential in BOLDER II trial

Article | 27 November 2006

Print This

Anglo-Swedish drug major AstraZeneca says that the results of a clinical trial of its drug Seroquel (quetiapine fumarate) indicate that ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in